SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-23-098511
Filing Date
2023-04-12
Accepted
2023-04-12 08:30:56
Documents
3
Period of Report
2023-05-23

Document Format Files

Seq Description Document Type Size
1 DEF 14A d380197ddef14a.htm DEF 14A 336162
2 GRAPHIC g380197dsp039.jpg GRAPHIC 122055
3 GRAPHIC g380197dsp040.jpg GRAPHIC 118432
  Complete submission text file 0001193125-23-098511.txt   668853
Mailing Address 5858 HORTON STREET #455 EMERYVILLE CA 94608
Business Address 5858 HORTON STREET #455 EMERYVILLE CA 94608 5105052680
4D Molecular Therapeutics, Inc. (Filer) CIK: 0001650648 (see all company filings)

IRS No.: 473506994 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39782 | Film No.: 23814698
SIC: 2836 Biological Products, (No Diagnostic Substances)